Referências

1. Barnett BE, 2016, J IMMUNOL, V197, P1017, DOI 10.4049/jimmunol.1500368
2. Cancro MP, 2020, ANNU REV IMMUNOL, V38, P315, DOI 10.1146/annurev-immunol-092419-031130
3. Carsetti R, 2022, CYTOM PART A, V101, P131, DOI 10.1002/cyto.a.24507
4. Fernandes JR, 2022, IMMUN AGEING, V19, DOI 10.1186/s12979-022-00267-y
5. Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530
6. Karnell JL, 2017, CELL IMMUNOL, V321, P40, DOI 10.1016/j.cellimm.2017.05.008
7. Li HF, 2016, J IMMUNOL, V196, P4064, DOI 10.4049/jimmunol.1501027
8. Li YZ, 2021, CLIN EXP IMMUNOL, V205, P119, DOI 10.1111/cei.13615
9. Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380
10. Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x
11. Nipper AJ, 2018, CLIN IMMUNOL, V193, P80, DOI 10.1016/j.clim.2018.02.003
12. Phalke S, 2018, CURR OPIN IMMUNOL, V55, P75, DOI 10.1016/j.coi.2018.09.007
13. Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462
14. Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250
15. Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110
16. Sachinidis Athanasios, 2020, Mediterr J Rheumatol, V31, P311, DOI 10.31138/mjr.31.3.311
17. Sanz I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02458
18. Thorarinsdottir K, 2016, CLIN EXP IMMUNOL, V185, P252, DOI 10.1111/cei.12795
19. Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7
20. Zeidel A, 2002, ACTA ANAESTH SCAND, V46, P959, DOI 10.1034/j.1399-6576.2002.460806.x